Portfolia’s FemTech II Fund has invested in xCures, the AI-powered platform that transforms multiple sources of medical data for patients and doctors evaluating cancer care. Nearly 40% of Americans will face a cancer diagnosis in their lifetime. Understanding a diagnosis and choosing a treatment plan can be overwhelming for patients. With xCures’ AI engine, patients and oncologists can cross reference vast amounts of research and therapies to make informed treatment choices for each unique diagnosis.
